海外上市

Switzerland/China IPOs: brand, not depth is the lure of ‘new New York’

Alpine nation has relaxed audit requirements and a reputation for financial sophistication

Switzerland is becoming the destination of choice for mainland Chinese companies seeking a foreign listing. Drugmaker Joincare Pharmaceutical Group is the latest to announce plans to float on the Swiss stock exchange.

Beijing hopes the alpine nation will be the new New York for companies seeking foreign funding. It may be disappointed

The SIX Swiss Exchange has recently been the choice for businesses including equipment maker Sany Heavy Industry, pharma group Lepu Medical and two electric car battery manufacturers, Gotion High-Tech and Ningbo Shanshan.

您已閱讀25%(556字),剩餘75%(1697字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×